| |
|
|
|
Institut Pasteur, Paris
October 20-21, 2005
Anti-infective therapies and preventive vaccines are facing new challenges: the global increase of resistant pathogens both in the community and hospitals, the emergence of new pathogens with their own potential intrinsic resistance, the existence of co-infections, and the increased number of susceptible hosts such as those iatrogenically immunodepressed and elderly. Regarding antimicrobial resistance, the World Health Organization Assembly in May 2005, will discuss one of the resolutions that deal with this worrying problem. European Union has already committed itself to combating resistance to anti-infective therapies, particularly antibiotic resistance.Among other initiatives, EU has banned antibiotics as growth-promoting additives to animal feed and favoured policy to limit their unrestricted use in clinical medicine. Nowadays, it is essential that all parties, practising physicians, academic researchers, industry and politicians join forces to combat antiinfective agents resistance. Furthermore, the problem is increased with the insufficient development of new and effective drugs targeting resistant micro-organisms. In addition, the economical cost of new anti-infective agents, which concerns both industrialized and developing countries, has to be taken into account.The Institut Pasteur holds a prime position in the world in research on infections and their treatment. In EUROCONFERENCE in Paris 20-21 October, 2005, leading scientists will present state-of-the-art in the field of anti-infective therapy, discuss the above issues and outline fields for future research and hope.
|
|
|
|
|
|
|
|
Organized by:
|
|
Institut Pasteur |
|
|
Invited Speakers:
|
|
Herman GOOSSENS, University of Antwerp, Belgium
Christopher C. BUTLER, Cardiff University, UK
Kathleen HOLLOWAY,WHO, Geneva, CH
Christina GREKO, National Veterinary Institute, Uppsala, Sweden
Yehuda CARMELI,Tel Aviv Medical Center, Israel
Barbara MINTZES, University of Sussex, Brighton, UK
Roger Finch, University of Nottingham, UK
Goran A.Ando, Novexel SA, Romainville, France
Peter L. Chiodini, Hospital for Tropical Diseases, London, UK
Fernando Baquero, Ramón y Cajal University Hospital, Madrid, Spain
Didier Guillemot, Institut Pasteur, Paris, France
S. Ragnar Norrby, Swedish Institute for Infectious Disease Controle, Solna, Sweden
Sri Suryawati, Gadjah Mada University, Yogyakarta, Indonesia
Juhani Eskola, National Public Health Institute, Helsinki, Finland
Michel G. Bergeron, Laval University, Sainte-Foy, Canada
Antoine Andremont, Groupe HospitalierBichat-Claude Bernard, Paris, France
Christopher A. Hitchcock, Pfizer Global Research R & D, Sandwich, UK
J.Todd Weber, National Center for Infectious Diseases, Centers for Disease Control and Prevention,Atlanta, USA
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
September 1,2005
|
|
|
|
|
|
|
|
Registration:
|
|
Please complete and return the registration form to:
INSTITUT PASTEUR Service Colloques - C.I.S. 28, rue du Docteur Roux,
75724 Paris Cedex 15, France - Fax : 33 1 40 61 30 25.
E-mail: euroconf-ip@pasteur.fr
We recommend early registration.
Payment to be made by check payable to « INSTITUT PASTEUR - Infection »
or by Credit Card (MasterCard or Visa only).
Fees : 150/450/1050 € until September 20, 2005
160/550/1250 € after September 20, 2005
|
|
|
E-mail:
|
|
euroconf-ip@pasteur.fr
|
|
|
|
|
|
|
|
|